---
title: "11 Health Care Stocks Moving In Thursday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291573098.md"
description: "During Thursday's intraday session, several healthcare stocks experienced significant volatility. Gainers included Chemomab Therapeutics (+33.8%), Liminatus Pharma (+26.04%), and Stablecoin Development (+25.48%). Conversely, major losers featured Elicio Therapeutics (-34.4%) and Profusa (-30.39%). Other notable decliners were INVO Fertility, Can Fite Biopharma, and Regencell Bioscience."
datetime: "2026-07-02T17:05:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291573098.md)
  - [en](https://longbridge.com/en/news/291573098.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291573098.md)
---

# 11 Health Care Stocks Moving In Thursday's Intraday Session

### Gainers

-   **Chemomab Therapeutics** (NASDAQ:CMMB) stock increased by 33.8% to $2.27 during Thursday's regular session. The market value of their outstanding shares is at $12.2 million.
-   **Liminatus Pharma** (NASDAQ:LIMN) shares rose 26.04% to $0.14. The market value of their outstanding shares is at $5.8 million.
-   **Stablecoin Development** (AMEX:SDEV) stock increased by 25.48% to $1.3. The market value of their outstanding shares is at $28.2 million.
-   **SL Science Holding** (NASDAQ:SLBT) stock increased by 24.26% to $5.53. The company's market cap stands at $2.4 billion.
-   **Propanc Biopharma** (NASDAQ:PPCB) shares increased by 21.41% to $1.75. The company's market cap stands at $3.2 million.
-   **Veraxa Biotech Holding** (NASDAQ:VRXA) shares increased by 17.68% to $2.03. The market value of their outstanding shares is at $243.9 million.

### Losers

-   **Elicio Therapeutics** (NASDAQ:ELTX) shares declined by 34.4% to $3.37 during Thursday's regular session. The market value of their outstanding shares is at $98.1 million.
-   **Profusa** (NASDAQ:PFSA) stock decreased by 30.39% to $0.09.
-   **INVO Fertility** (NASDAQ:IVF) stock fell 15.31% to $1.55. The company's market cap stands at $3.2 million.
-   **Can Fite Biopharma** (AMEX:CANF) shares decreased by 15.04% to $3.93. The company's market cap stands at $9.9 million.
-   **Regencell Bioscience** (NASDAQ:RGC) stock declined by 14.82% to $6.84. The market value of their outstanding shares is at $3.9 billion. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [LIMN.US](https://longbridge.com/en/quote/LIMN.US.md)
- [ELTX.US](https://longbridge.com/en/quote/ELTX.US.md)
- [CMMB.US](https://longbridge.com/en/quote/CMMB.US.md)
- [PFSA.US](https://longbridge.com/en/quote/PFSA.US.md)
- [IVF.US](https://longbridge.com/en/quote/IVF.US.md)
- [SDEV.US](https://longbridge.com/en/quote/SDEV.US.md)
- [RGC.US](https://longbridge.com/en/quote/RGC.US.md)
- [CANF.US](https://longbridge.com/en/quote/CANF.US.md)
- [SLBT.US](https://longbridge.com/en/quote/SLBT.US.md)
- [PPCB.US](https://longbridge.com/en/quote/PPCB.US.md)
- [VRXA.US](https://longbridge.com/en/quote/VRXA.US.md)
- [LIMNW.US](https://longbridge.com/en/quote/LIMNW.US.md)
- [PPCBD.US](https://longbridge.com/en/quote/PPCBD.US.md)
- [NVACW.US](https://longbridge.com/en/quote/NVACW.US.md)

## Related News & Research

- [Liminatus Pharma discloses Ewon Comfortech initial beneficial ownership of 5.5 million shares](https://longbridge.com/en/news/291844263.md)
- [Chemomab Therapeutics: Merger creates an AI-powered precision medicine leader advancing nebokitug for RA with $30M funding](https://longbridge.com/en/news/292066923.md)
- [INVO Fertility Q1 revenue jumps on clinic growth, acquisition](https://longbridge.com/en/news/290441756.md)
- [INVO Fertility Gains Full Control of Alabama Clinic](https://longbridge.com/en/news/290882136.md)
- [Can-Fite Highlights Survival Outcomes In Pancreatic Cancer Patients](https://longbridge.com/en/news/291432421.md)